Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Adjuvant everolimus did not benefit high-risk renal cell carcinoma
Home
Publications
Adjuvant everolimus did not benefit high-risk renal cell carcinoma
Adjuvant everolimus did not benefit high-risk renal cell carcinoma
CR
Christopher Ryan
Christopher Ryan
RH
Robert van Den Heuvel
Robert van Den Heuvel
Publisher Website
Google Scholar
Cite
Download
Share
Download
5 August 2022
conference paper
conference paper
Published by
Medicom Medische Uitgeverij BV
in
Medicom Conference Report ASCO 2022
https://doi.org/10.55788/26bc2105
Abstract
No abstract available